
Researchers activate gene to reverse depression in mice
pharmafile | February 18, 2019 | News story | Sales and Marketing | SIRT1, depression, genetics, mental health
Scientists at the Medical College of Georgia at Augusta University were able to directly activate a gene associated with depression and thus reverse symptoms of depression in male mice, according to a study published in the journal Molecular Psychiatry.
In looking into the prefrontal cortex, the researchers found that making the SIRT1 gene inactive in excitatory neurons created symptoms of depression in male mice. A drug that activated SIRT1 thus reversed the symptoms of depression.
The researchers believe that the firing of excitatory neurons was decreased in those with depression and thus drugs that target SIRT1, which promote activity in the excitatory neurons, may be key to treating depression. “It’s like they are disconnected,” said Xin-Yun Lu who led the research.
Alternatively excessive firing in the excitatory neurons can lead to other problems such as manic episodes and seizures.
Thus drugs that activate the SIRT1 gene may one day be effective therapies for major depression. Lu now plans to look at existing drugs and explore the effects that they have on the SIRT1 gene.
Louis Goss
Related Content

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases
The 80th United Nations General Assembly (UNGA) has adopted the political declaration to combat mental …

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety
The potential benefits of digital mental health technology for managing depression, anxiety and stress, together …

Alto Neuroscience announces new patent for depression treatment
Alto Neuroscience, a clinical-stage biopharmaceutical company specialising in precision treatments for neuropsychiatric conditions, has announced …





